Outcome of in-hospital cardiac arrests (IHCAs) in AHEPA University Hospital in 1000 patients, all of whom received cardiopulmonary resuscitation by health care staff.

开始日期2024-06-01

申办/合作机构

University Hospital AHEPA

ISRCTN14477643 / CompletedN/AIIT

VIRTUal Simulator mobile ApplicatioN (VIRTUSAN), a promising and challenging educational tool for digital health empowerment. A four-dimensional pillar implementation journey for optimum cardiometabolic lifestyle and quality of life, implementing nutritional, physical, mental and sleep habits. The VIRTUSAN Clinical Trial.

开始日期2022-09-01

申办/合作机构

University Hospital AHEPA

NCT05858372 / CompletedN/AIIT

Effects of Chios Mastiha Essential Oil on Cholesterol Levels of Healthy Volunteers: a Prospective, Randomized, Placebo-controlled Study (MASTIHA-OIL Study)

A prospective, randomized, placebo-controlled study was designed to study the hypolipidemic effect of CMO capsules on healthy volunteers with elevated cholesterol levels.

开始日期2022-07-01

申办/合作机构

University Hospital AHEPA

100 项与 University Hospital AHEPA 相关的临床结果

登录后查看更多信息

0 项与 University Hospital AHEPA 相关的专利（医药）

登录后查看更多信息

1,297

项与 University Hospital AHEPA 相关的文献（医药）

2024-10-01·Neurological Sciences

Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study

Article

作者: Deleu, Dirk ; Lotti, Enrico M ; Baronello, Mario M ; Becattini, Cecilia ; Alberti, Andrea ; Makaritsis, Kostantinos ; Chiti, Alberto ; Michel, Patrik ; Giuntini, Martina ; Vadikolias, Kostantinos ; Pezzini, Alessandro ; Karapanayiotides, Theodore ; Volodina, Vera ; Toni, Danilo ; Sagris, Dimitrios ; Pieroni, Alessio ; D'Amore, Cataldo ; Chondrogianni, Maria ; Mancuso, Michelangelo ; Giorli, Elisa ; Marcheselli, Simona ; Venti, Michele ; Rueckert, Christina ; Cappellari, Manuel ; Abdul-Rahim, Azmil H ; Cancelloni, Virginia ; Vanacker, Peter ; Gourbali, Vanessa ; Sohn, Sung-I I ; Adamou, Anastasia ; Tatlisumak, Turgut ; Mosconi, Maria G ; Bellesini, Marta ; Caso, Valeria ; Buratti, Mariachiara ; Halvatsiotis, Panagiotis ; Del Sette, Massimo ; Palaiodimou, Lina ; Agnelli, Giancarlo ; Ciccone, Alfonso ; Doronin, Boris ; Tadi, Prasanna ; Guideri, Francesca ; Kepplinger, Jessica ; Yaghi, Shadi ; Lorenzini, Gianni ; Csiba, Laszlò ; Paciaroni, Maurizio ; Silvestrelli, Giorgio ; Szabò, Lilla ; Putaala, Jukka ; Ntaios, George ; Tassi, Rossana ; Barlinn, Kristian ; Tsivgoulis, Georgios ; Acampa, Maurizio ; Tassinari, Tiziana ; Corea, Francesco ; Furie, Karen L ; Galati, Franco ; de Magistris, Ilaria Leone ; Monaco, Serena ; Sacco, Simona ; Mumoli, Nicola ; Flomin, Yuriy ; Bandini, Fabio ; Orlandi, Giovanni ; Ageno, Walter ; Pascarella, Rosario ; Cimini, Ludovica A ; Lettieri, Federica ; Kargiotis, Odysseas ; Tomppo, Liisa ; Imberti, Davide ; Pallesen, Lars P ; Tiseo, Cindy ; Athanasakis, George ; Acciarresi, Monica ; Baldi, Antonio ; Karagkiozi, Efstathia ; Zabzuni, Dorjan ; Zedde, Marialuisa

AbstractBackgroundIntravenous thrombolysis (IVT) and/or endovascular therapy (EVT) are currently considered best practices in acute stroke patients. Data regarding the efficacy and safety of reperfusion therapies in patients with atrial fibrillation (AF) are conflicting as regards haemorrhagic transformation, mortality, and functional outcome. This study sought to investigate for any differences, in terms of safety and effectiveness, between AF patients with acute ischaemic stroke (AIS) treated and untreated with reperfusion therapies.MethodsData from two multicenter cohort studies (RAF and RAF-NOACs) on consecutive patients with AF and AIS were analyzed to compare patients treated and not treated with reperfusion therapies (IVT and/or EVT). Multivariable logistic regression analysis was performed to identify independent predictors for outcome events: 90-day good functional outcome and mortality. A propensity score matching (PSM) analysis compared treated and untreated patients.ResultsOverall, 441 (25.4%) were included in the reperfusion-treated group and 1,295 (74.6%) in the untreated group. The multivariable model suggested that reperfusion therapies were significantly associated with good functional outcome. Rates of mortality and disability were higher in patients not treated, especially in the case of higher NIHSS scores. In the PSM comparison, 173/250 patients (69.2%) who had received reperfusion therapies had good functional outcome at 90 days, compared to 146/250 (58.4%) untreated patients (p = 0.009, OR: 1.60, 95% CI:1.11–2.31).ConclusionsPatients with AF and AIS treated with reperfusion therapies had a significantly higher rate of good functional outcome and lower rates of mortality compared to those patients with AF and AIS who had undergone conservative treatment.

2024-09-01·Medical Mycology Case Reports

Fatal misdiagnosis of progressive disseminated histoplasmosis

Article

作者: Theotokis, Paschalis ; Meditskou, Soultana ; Spaho, Marina ; Manthou, Maria Eleni ; Vasilopoulou, Anthi ; Grekou, Alexandra

Disseminated histoplasmosis is the form of a mycosis caused by the fungus Histoplasma capsulatum that mainly occurs in immunosuppressed hosts, usually with non-specific symptoms. In non-endemic areas, where the disease is rarely involved in the differential diagnosis, a delay in treatment may lead to severe medical complications. Due to the rising prevalence of disseminated histoplasmosis in these areas, a thorough medical history is regarded as the decisive factor in prompt diagnosis of the disease. We, herein, report the case of an immunocompetent Greek farmer with disseminated histoplasmosis whose condition was initially misdiagnosed, and the consequential inadequate treatment led to his death.

2024-09-01·Surgery

Response to “Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy”

Letter

作者: Cheva, Angeliki ; Chorti, Angeliki ; Papavramidis, Theodossis

100 项与 University Hospital AHEPA 相关的药物交易

登录后查看更多信息

100 项与 University Hospital AHEPA 相关的转化医学

登录后查看更多信息